Literature DB >> 27393118

The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Wei-Xi Xiong1, Yi-Min Sun1, Rong-Yuan Guan1, Su-Shan Luo1, Chen Chen1, Yu An2, Jian Wang3, Jian-Jun Wu4,5.   

Abstract

The missense mutation A53T of alpha-synuclein gene (SNCA) was reported to be a rare but definite cause of sporadic and familial Parkinson disease (PD). It seemed to be restricted geographically in Greece and Italy. We aimed to identify the SNCA mutations in a Chinese PD cohort. Ninety-one early onset PD patients or familial PD probands were collected consecutively for the screening of PD-related genes. The genetic analysis was carried out by target sequencing of the exons and the corresponding flanking regions of the PD-related genes using Illumina HiSeq 2000 sequencer and further confirmed by Sanger sequencing or restriction fragment length polymorphism. Dosage mutations of exons in these genes were carried out by multiple ligation-dependent probe amplification. Among the 91 patients, we found only one heterozygous mutation of SNCA A53T, in a 23-year-old male patient with negative family history. The [(11)C]-2β-carbomethoxy-3β-(4-fluorophenyl) tropan (CFT) PET and PD-related spatial covariance pattern (PDRP) via [(18)F]-fluorodeoxyglucos (FDG) PET confirmed a typical pattern of PD. After examining his parents, we found his mother was an asymptomatic carrier, with declined hand dexterity detected by quantitative motor tests. Reduced dopamine transporter uptake of his mother was identified by CFT PET, and abnormal PDRP pattern was found by FDG PET. Our investigation expanded the clinical and genetic spectrum of Chinese PD patients, and we suggested SNCA mutations to be screened in familial and early onset Chinese PD patients.

Entities:  

Keywords:  A53T alpha-synuclein mutation; Dopamine transporter; PET; Parkinson disease; Parkinson’s disease-related spatial covariance pattern

Mesh:

Substances:

Year:  2016        PMID: 27393118     DOI: 10.1007/s00415-016-8213-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  60 in total

1.  Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.

Authors:  A Athanassiadou; G Voutsinas; L Psiouri; E Leroy; M H Polymeropoulos; A Ilias; G M Maniatis; T Papapetropoulos
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.

Authors:  C-S Ki; E F Stavrou; N Davanos; W Y Lee; E J Chung; J-Y Kim; A Athanassiadou
Journal:  Clin Genet       Date:  2007-05       Impact factor: 4.438

Review 3.  Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.

Authors:  Shigeki Hirano; Thomas Eckert; Toni Flanagan; David Eidelberg
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

4.  Lack of mutation G209A in the alpha-synuclein gene in French patients with familial and sporadic Parkinson's disease.

Authors:  G Lucotte; G Mercier; J C Turpin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Cognitive impairment in mild general paresis of the insane: AD-like pattern.

Authors:  Jianhong Wang; Qihao Guo; Pingyu Zhou; Jun Zhang; Qianhua Zhao; Zhen Hong
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-18       Impact factor: 2.959

Review 7.  A narrative review of dexterity assessments.

Authors:  Katie E Yancosek; Dana Howell
Journal:  J Hand Ther       Date:  2009-02-12       Impact factor: 1.950

8.  (123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A.

Authors:  Sevasti Bostantjopoulou; Zoe Katsarou; George Gerasimou; Durval C Costa; Anna Gotzamani-Psarrakou
Journal:  Hell J Nucl Med       Date:  2008 Sep-Dec       Impact factor: 1.102

9.  Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.

Authors:  Dimitra Papadimitriou; Roubina Antonelou; Michael Miligkos; Matina Maniati; Nikolaos Papagiannakis; Sevasti Bostantjopoulou; Athannassios Leonardos; Christos Koros; Athina Simitsi; Sokratis G Papageorgiou; Elisabeth Kapaki; Roy N Alcalay; Alexandros Papadimitriou; Aglaia Athanassiadou; Maria Stamelou; Leonidas Stefanis
Journal:  Mov Disord       Date:  2016-03-29       Impact factor: 10.338

Review 10.  Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models.

Authors:  Simona Petrucci; Monia Ginevrino; Enza Maria Valente
Journal:  Parkinsonism Relat Disord       Date:  2015-08-18       Impact factor: 4.891

View more
  4 in total

Review 1.  α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Authors:  Kaie Rosborough; Neha Patel; Lorraine V Kalia
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

2.  TMEM230 Mutations Are Rare in Han Chinese Patients with Autosomal Dominant Parkinson's Disease.

Authors:  Qianqian Wei; Ruwei Ou; Qingqing Zhou; Yongping Chen; Bei Cao; Xiaojing Gu; Bi Zhao; Ying Wu; Wei Song; Hui-Fang Shang
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

3.  A novel mutation of VAPB in one Chinese familial amyotrophic lateral sclerosis pedigree and its clinical characteristics.

Authors:  Yi-Min Sun; Yi Dong; Jian Wang; Jia-Hong Lu; Yan Chen; Jian-Jun Wu
Journal:  J Neurol       Date:  2017-10-09       Impact factor: 4.849

4.  Olfaction in Parkin carriers in Chinese patients with Parkinson disease.

Authors:  Ying Wang; Jian-Jun Wu; Feng-Tao Liu; Kui Chen; Chen Chen; Su-Shan Luo; Yi-Xuan Wang; Da-Ke Li; Rong-Yuan Guan; Yu-Jie Yang; Yu An; Jian Wang; Yi-Min Sun
Journal:  Brain Behav       Date:  2017-03-28       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.